Delayed
TEL AVIV STOCK EXCHANGE
08:49:49 2024-05-12 am EDT
|
5-day change
|
1st Jan Change
|
852.3
ILa
|
+0.84%
|
|
+2.33%
|
-3.59%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
906.9
|
1,505
|
1,362
|
1,421
|
1,223
|
1,329
|
Enterprise Value (EV)
1 |
1,085
|
1,641
|
1,540
|
1,557
|
1,572
|
2,024
|
P/E ratio
|
14.5
x
|
18.2
x
|
-107
x
|
4.83
x
|
10.2
x
|
6.05
x
|
Yield
|
6.84%
|
-
|
-
|
9.14%
|
4.9%
|
6.01%
|
Capitalization / Revenue
|
5.2
x
|
7.7
x
|
6.59
x
|
6.67
x
|
5.22
x
|
5.52
x
|
EV / Revenue
|
6.22
x
|
8.4
x
|
7.45
x
|
7.31
x
|
6.71
x
|
8.41
x
|
EV / EBITDA
|
62.4
x
|
88.2
x
|
61.2
x
|
84.7
x
|
59.6
x
|
42.7
x
|
EV / FCF
|
5.78
x
|
4.6
x
|
-8.53
x
|
4.37
x
|
17.7
x
|
-58.5
x
|
FCF Yield
|
17.3%
|
21.8%
|
-11.7%
|
22.9%
|
5.65%
|
-1.71%
|
Price to Book
|
1.13
x
|
1.72
x
|
1.63
x
|
1.3
x
|
1.08
x
|
1.02
x
|
Nbr of stocks (in thousands)
|
143,051
|
150,034
|
150,053
|
150,082
|
150,146
|
150,393
|
Reference price
2 |
6.340
|
10.03
|
9.080
|
9.470
|
8.147
|
8.840
|
Announcement Date
|
3/18/19
|
3/22/20
|
3/22/21
|
3/22/22
|
3/26/23
|
3/27/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
174.5
|
195.4
|
206.6
|
213.1
|
234.3
|
240.8
|
EBITDA
1 |
17.38
|
18.61
|
25.16
|
18.38
|
26.36
|
47.42
|
EBIT
1 |
16.39
|
17.19
|
23.35
|
16.4
|
11.11
|
46.27
|
Operating Margin
|
9.39%
|
8.8%
|
11.3%
|
7.7%
|
4.74%
|
19.21%
|
Earnings before Tax (EBT)
1 |
117
|
146.5
|
-9.314
|
449
|
172.9
|
322.4
|
Net income
1 |
62.73
|
81.1
|
-12.74
|
296.7
|
120.9
|
220.6
|
Net margin
|
35.95%
|
41.52%
|
-6.17%
|
139.22%
|
51.61%
|
91.61%
|
EPS
2 |
0.4385
|
0.5500
|
-0.0849
|
1.960
|
0.8000
|
1.460
|
Free Cash Flow
1 |
187.7
|
357
|
-180.5
|
356
|
88.88
|
-34.62
|
FCF margin
|
107.56%
|
182.76%
|
-87.34%
|
167.07%
|
37.94%
|
-14.38%
|
FCF Conversion (EBITDA)
|
1,079.76%
|
1,918.74%
|
-
|
1,936.9%
|
337.15%
|
-
|
FCF Conversion (Net income)
|
299.21%
|
440.21%
|
-
|
120.01%
|
73.51%
|
-
|
Dividend per Share
2 |
0.4334
|
-
|
-
|
0.8660
|
0.3989
|
0.5316
|
Announcement Date
|
3/18/19
|
3/22/20
|
3/22/21
|
3/22/22
|
3/26/23
|
3/27/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
178
|
136
|
177
|
136
|
349
|
695
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
10.22
x
|
7.314
x
|
7.038
x
|
7.404
x
|
13.24
x
|
14.65
x
|
Free Cash Flow
1 |
188
|
357
|
-180
|
356
|
88.9
|
-34.6
|
ROE (net income / shareholders' equity)
|
8.45%
|
10.4%
|
-1.19%
|
30.1%
|
10.7%
|
17%
|
ROA (Net income/ Total Assets)
|
0.29%
|
0.28%
|
0.35%
|
0.22%
|
0.14%
|
0.54%
|
Assets
1 |
21,490
|
29,310
|
-3,642
|
132,089
|
87,180
|
41,091
|
Book Value Per Share
2 |
5.620
|
5.830
|
5.560
|
7.280
|
7.540
|
8.640
|
Cash Flow per Share
2 |
1.700
|
1.930
|
3.490
|
3.630
|
1.860
|
1.980
|
Capex
1 |
2.74
|
0.91
|
1.35
|
0.7
|
0.85
|
0.41
|
Capex / Sales
|
1.57%
|
0.47%
|
0.65%
|
0.33%
|
0.36%
|
0.17%
|
Announcement Date
|
3/18/19
|
3/22/20
|
3/22/21
|
3/22/22
|
3/26/23
|
3/27/24
|
|
1st Jan change
|
Capi.
|
---|
| -3.59% | 344M | | -17.59% | 2.39B | | +2.74% | 1.46B | | -27.39% | 1.43B | | +21.31% | 1.36B | | +31.77% | 809M | | -10.00% | 435M | | +234.05% | 424M | | +9.41% | 136M | | +46.62% | 95.83M |
Residential & Long-Term Care
|